HESG OTC
Health Sciences Group, Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: +0.0%
1Y: -90.0%
3Y: -99.0%
5Y: -99.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±9874.5%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$42K
+0.0% ▲
Capital Expenditures
$2
+0.0% ▲
5Y CAGR: -84.2%
Free Cash Flow
$42K
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$0
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2002 | FY2003 | FY2004 | FY2005 | FY2012 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$7M | -$10M | -$6M | -$54K |
| Depreciation & Amort. | $305K | $1M | $1M | $3M | $10K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$138K | $735K | $1M | -$327K | $96K |
| Other Non-Cash Items | $4M | $4M | $7M | -$173K | -$10K |
| Operating Cash Flow | -$596K | -$1M | -$1M | -$4M | $42K |
| — Investing Activities — | |||||
| Capital Expenditures | -$19K | -$94K | -$3K | -$360K | $0 |
| Acquisitions (Net) | $0 | -$242K | $212K | $200K | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$19K | -$337K | $210K | -$160K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$130K | -$298K | $32K | -$35K | -$3K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $421K | -$250K | -$758K | -$108K | $0 |
| Financing Cash Flow | $784K | $2M | $820K | $4M | -$3K |
| Net Change in Cash | $169K | $96K | -$25K | -$219K | $0 |
| Cash End of Period | $169K | $265K | $241K | $21K | $1K |
| Free Cash Flow | -$615K | -$1M | -$1M | -$4M | $42K |